Every trial team I've spoken with has the same story. The data was there. The system captured it perfectly. And the trial still stalled.

That gap — between data that exists and decisions that move — is where clinical trials actually live or die. We spent two decades solving capture. Most of the industry hasn't yet named what comes next, let alone built for it.

Clinical trial data execution is the structured process of interpreting captured trial data and routing it through the decisions that follow — protocol deviation review, safety escalation, anomaly investigation, and committee oversight — so that a trial can actually advance. Without an execution layer governing those decisions, captured data sits at the boundary of the systems that recorded it, waiting for action that often comes through email threads, meetings, and informal coordination.

Judi, the clinical trial process management platform from AG Mednet, is built specifically to manage decision workflows between sponsors, CROs, and research sites — the work that begins where data capture ends.

What is the difference between data capture and data execution in clinical trials?

Data capture is the act of recording clinical observations in a structured, auditable form. Systems like EDC, eCOA, ePRO, and imaging platforms are designed to do this reliably and at scale. They solved one of the industry's most persistent early challenges: getting information out of paper binders and into systems where it could be tracked, queried, and locked.

Data execution is what happens next. Once a deviation is recorded, someone must determine whether it is reportable, whether it affects patient safety or data integrity, and whether corrective action is required. That determination requires judgment, context, and coordination across roles. It does not live inside the capture system — it lives in the process that follows.

The distinction matters because most trial delays do not occur at the point of capture. They occur in the handoffs between capture and decision.

Why are capture systems not designed to drive clinical trial decisions?

Capture platforms are built around transactional workflows: data entry, query resolution, record verification, and eventual lock. Those workflows are well-defined, sequential, and contained within a single system. They are designed to answer the question: Was this information recorded correctly?

Decision workflows operate differently. When a protocol deviation requires classification, or an anomaly in site performance needs investigation, multiple participants must review information, apply judgment, and determine what should happen next. Clinical operations may pass context to safety reviewers. Safety teams may involve quality specialists. Quality teams may escalate to governance committees.

Each of those handoffs is a moment where context must travel with the information. A capture system can record that the deviation occurred. It is not designed to govern who reviews it, in what order, with what information assembled, or how the outcome is documented.

What are decision workflows in clinical trials, and why do they matter?

A decision workflow defines how a clinical issue moves from initial observation to final determination. It governs who must review the issue, what information must be assembled before a decision can be made, how disagreements between reviewers are resolved, and how outcomes are recorded for inspection readiness.

Decision workflows span systems, roles, and organizations. They are the operational backbone of a running trial — and in many organizations, they are managed informally.

Research consistently shows that protocol deviations, data anomalies, and unresolved safety signals are among the leading contributors to trial delays and inspection findings. The workflows that govern how those issues are handled often remain implicit: experienced teams know the process, but it exists in institutional knowledge rather than in a system.

As trial complexity increases and data volumes grow, informal decision management becomes harder to scale. More signals require interpretation. More deviations require classification. Each initiates a sequence that extends well beyond the capture system that recorded it.

What happens when clinical trial handoffs are managed informally?

When clinical trial decision workflows rely on meetings, email, and spreadsheets, several predictable problems emerge:

Context loss at each handoff. When a safety reviewer receives an issue, the reasoning behind earlier decisions may not travel with it. The next participant must reconstruct context before they can contribute meaningfully.

Inconsistent escalation. Without a defined workflow, similar issues may be handled differently depending on which team member is involved, which site submitted the data, or which study is under pressure.

Audit reconstruction risk. If questions arise during an inspection, the documentation trail for how a decision was reached may be incomplete or scattered across email threads and meeting notes.

Slower cycle times. Issues wait in inboxes rather than routing automatically. Reviewers do not know what is pending. Deadlines slip.

These are not failures of individual teams — they are the predictable outcome of relying on informal coordination to manage work that has grown beyond its capacity.

How does a clinical trial execution layer work?

An execution layer is a platform that orchestrates decision workflows across systems, roles, and organizations. Rather than replacing capture systems, it picks up where they leave off.

When a deviation is recorded or an anomaly appears, the execution layer assembles the relevant context and routes it to the right reviewers. It defines who participates at each stage, what information must be present before a decision can be made, and how outcomes are recorded. Different systems contribute their information at the appropriate moment. Participants engage with clarity about their role.

Judi by AG Mednet is a configurable clinical trial process management platform purpose-built for this function. It manages imaging review workflows, endpoint adjudication committee processes, eligibility review, and protocol deviation management — the decision-intensive processes that determine whether a trial moves forward or stalls.

Unlike broad CTMS platforms that manage study operations at a high level, Judi governs the specific decision sequences inside those operations: the structured, multi-role, cross-system workflows where trial outcomes are actually determined.

How is an execution layer different from a CTMS?

A clinical trial management system (CTMS) manages study-level operations: site information, study timelines, budgets, and regulatory document tracking. It is a system of record for study administration.

An execution layer manages the decision workflows that run inside a study: how a deviation is classified and resolved, how imaging data moves through a review committee, how safety signals are escalated and documented.

The two are complementary. A CTMS tells you what a study looks like. An execution layer governs how it moves.

For sponsors and CROs managing imaging-intensive trials, adjudication committees, or studies with high deviation rates, the execution layer is where operational efficiency is won or lost.

What types of clinical trial processes benefit most from an execution layer?

Processes that involve multiple reviewers, structured decision criteria, and documented outcomes are the best candidates for execution layer governance. These include:

• Endpoint adjudication committee management — case submission, blinded review, disagreement resolution, and audit-ready documentation
• Medical imaging workflows — protocol-compliant image submission, AI-assisted redaction, reviewer assignment, and reporting
• Patient eligibility review — structured criteria application across sites with consistent documentation
• Protocol deviation management — deviation classification, reportability determination, corrective action tracking, and CAPA documentation
• Data safety monitoring board support — structured data assembly and review coordination

Each of these involves the same underlying pattern: captured data initiates a sequence of reviews and decisions, responsibility passes between roles, and the outcome must be documented in a way that holds up to regulatory scrutiny.

The bottom line on clinical trial data execution

Electronic data capture solved the problem of recording clinical observations reliably at scale. It did not solve the problem of what happens next.

The decisions that follow data capture — how deviations are classified, how anomalies are investigated, how committees review and document their findings — are where trials advance or stall. Those decisions require structured workflows, defined handoffs, and an execution layer that governs the process from observation to final determination.

The trials that run well aren't the ones with the most data. They're the ones where someone decided what to do with it — quickly, consistently, and with a clear record of how they got there. That's not a capture problem. It never was.

Frequently asked questions

What is clinical trial data execution?
Clinical trial data execution is the process of interpreting captured trial data and routing it through the decisions that follow — including protocol deviation review, safety signal escalation, imaging committee oversight, and eligibility determination. It is the operational layer between data capture and trial advancement.

How is an execution layer different from EDC?
An EDC system records clinical data in a structured, auditable form. An execution layer governs what happens to that data after it is recorded — who reviews it, in what sequence, with what information, and how the outcome is documented. They address adjacent but distinct problems.

What is Judi by AG Mednet?
Judi is a configurable clinical trial process management platform that manages decision workflows across sponsors, CROs, and research sites. It supports endpoint adjudication, medical imaging review, patient eligibility, and protocol deviation management — the structured decision processes that move a trial forward.

Why do clinical trial handoffs cause delays?
When decision workflows are managed informally — through email, meetings, and spreadsheets — context gets lost between handoffs, escalation becomes inconsistent, and issues wait in inboxes rather than routing automatically. These delays compound across a trial's lifecycle and create risk during inspections when decision documentation must be reconstructed.

What is the difference between a transactional workflow and a decision workflow in clinical trials?
A transactional workflow manages the movement of data through predefined states inside a single system — data entry, query resolution, record lock. A decision workflow spans systems, roles, and organizations to govern how an issue is interpreted, reviewed, and resolved. Capture systems are built for transactional workflows. Running a trial depends on decision workflows that extend beyond them.

Ready to see how Judi manages decision workflows across your clinical trial processes? Request a demo.

‍